The comprehensive genetic profiling of tumors made possible by novel detection technologies has resulted in the identification of multiple cancers with rare RET alterations beyond point mutations and fusions (16, 17), including a nonnegligible number of RET deletions. The gene discussed is RET; the disease is cancer.